title: Typical absence status in adults: diagnostic and syndromic considerations.
abstract: OBJECTIVE
  To study the electroclinical features of typical absence status (TAS) in adults with syndromes of idiopathic generalized epilepsies (IGEs).
  
  
  METHODS
  Twenty-one patients with one or more spells of TAS were identified among 136 consecutive adult patients with IGEs. All patients with TAS had comprehensive electroclinical investigations and EEG or video-EEG recorded absences.
  
  
  RESULTS
  TAS occurred in 24.4% of 86 patients who had IGEs with typical absences alone or in combination with other seizures presisting in adult life. The prevalence of TAS appeared to be syndrome related, ranging from as high as 57.1% in perioral myoclonia with absences and 46.2% in "phantom" absences with GTCS to as low as 6.7% in juvenile myoclonic epilepsy. A varying degree of impairment of cognition was the cardinal clinical symptom shared in all TAS, but corresponding syndromes of IGE were often betrayed by other symptoms such as eyelid or perioral myoclonia. In phantom absences with GTCS, TAS was more numerous (p < or = 0.05) and more frequently the first overt seizure type (p = 0.006) than in any other IGE. Only in the syndrome of eyelid myoclonia with absences, TAS was always situation related, mainly as a result of antiepileptic drug discontinuation.
  
  
  CONCLUSIONS
  The clinical EEG semiology and prevalence of TAS appear to be syndrome related with the highest prevalence in the syndromes of perioral myoclonia with absences and phantom absences with GTCS (p = 0.0024).
authors.affiliation: Department of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London, England.
authors.forename: A
authors.initials: A
authors.lastname: Agathonikou
authors.forename: C P
authors.initials: CP
authors.lastname: Panayiotopoulos
authors.forename: S
authors.initials: S
authors.lastname: Giannakodimos
authors.forename: M
authors.initials: M
authors.lastname: Koutroumanidis
mesh_terms: D000328:Adult; D000367:Age Factors; D000927:Anticonvulsants / Q000627:therapeutic use; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology; D015897:Comorbidity; D004569:Electroencephalography / Q000706:statistics & numerical data*; D004831:Epilepsies, Myoclonic / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology; D004832:Epilepsy, Absence / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology; D004829:Epilepsy, Generalized / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D008131:London / Q000453:epidemiology; D008991:Monitoring, Physiologic; D015995:Prevalence; D013577:Syndrome; D016896:Treatment Outcome; D014743:Videotape Recording
chemical_list: D000927:Anticonvulsants